Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

Similar articles for PubMed (Select 1320740)

1.

A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children.

Werzberger A, Mensch B, Kuter B, Brown L, Lewis J, Sitrin R, Miller W, Shouval D, Wiens B, Calandra G, et al.

N Engl J Med. 1992 Aug 13;327(7):453-7.

2.

Placebo-controlled efficacy study of hepatitis A vaccine in Valdivia, Chile.

Riedemann S, Reinhardt G, Frösner GG, Ibarra H, Moraleda L, Hering V, Siegel F, Toledo C, Leon J, Gonzalez JL, et al.

Vaccine. 1992;10 Suppl 1:S152-5.

PMID:
1335650
3.

Protection against hepatitis A by an inactivated vaccine.

Innis BL, Snitbhan R, Kunasol P, Laorakpongse T, Poopatanakool W, Kozik CA, Suntayakorn S, Suknuntapong T, Safary A, Tang DB, et al.

JAMA. 1994 May 4;271(17):1328-34.

PMID:
8158817
4.

Immunogenicity and safety of an inactivated hepatitis A vaccine in Taiwanese adults and children.

Lee CY, Huang LM, Lee PI, Chiu HH, Dumas R, Milcamps B, Lin W.

Southeast Asian J Trop Med Public Health. 2000 Mar;31(1):29-36.

PMID:
11023061
5.

Efficacy of virosome hepatitis A vaccine in young children in Nicaragua: randomized placebo-controlled trial.

Mayorga Pérez O, Herzog C, Zellmeyer M, Loáisiga A, Frösner G, Egger M.

J Infect Dis. 2003 Sep 1;188(5):671-7. Epub 2003 Aug 11.

6.

Single and booster dose responses to an inactivated hepatitis A virus vaccine: comparison with immune serum globulin prophylaxis.

Shouval D, Ashur Y, Adler R, Lewis JA, Armstrong ME, Davide JP, McGuire B, Kuter B, Brown L, Miller W, et al.

Vaccine. 1993;11 Suppl 1:S9-14.

PMID:
8383390
7.

Immunogenicity of inactivated hepatitis A vaccine in children.

Lee SD, Lo KJ, Chan CY, Yu MY, Wang YJ, Safary A.

Gastroenterology. 1993 Apr;104(4):1129-32.

PMID:
8462802
8.

The effect of age and weight on the response to formalin inactivated, alum-adjuvanted hepatitis A vaccine in healthy adults.

Reuman PD, Kubilis P, Hurni W, Brown L, Nalin D.

Vaccine. 1997 Jul;15(10):1157-61.

PMID:
9269062
9.

Inactivated hepatitis A vaccine in childhood: implications for disease control.

Nalin D, Brown L, Kuter B, Patterson C, McGuire B, Werzberger A, Santosham M, Block S, Reisinger K, Watson B, et al.

Vaccine. 1993;11 Suppl 1:S15-7.

PMID:
8383388
10.

Safety, immunogenicity and antibody persistence of an inactivated hepatitis A vaccine in 4 to 15 year old children.

Castillo de Febres O, Chacon de Petrola M, Casanova de Escalona L, Naveda O, Naveda M, Estopinan M, Bordones G, Zambrano B, Garcia A, Dumas R.

Vaccine. 1999 Nov 12;18(7-8):656-64.

PMID:
10547425
11.

Reactogenicity and immunogenicity of three different lots of a hepatitis A vaccine.

Theilmann L, Kallinowski B, Gmelin K, Hofmann F, Scheiermann N, Wohland B, Stickl H, Maiwald H, Moriabadi FK, Bock HL, et al.

Vaccine. 1992;10 Suppl 1:S132-4.

PMID:
1335644
12.

Safety and immunogenicity of hepatitis A vaccine in healthy children.

Horng YC, Chang MH, Lee CY, Safary A, Andre FE, Chen DS.

Pediatr Infect Dis J. 1993 May;12(5):359-62.

PMID:
8392163
13.

Simultaneous active and passive immunization against hepatitis A studied in a population of travellers.

Wagner G, Lavanchy D, Darioli R, Pécoud A, Brulein V, Safary A, Frei PC.

Vaccine. 1993;11(10):1027-32.

PMID:
8212822
14.

Immunogenicity, safety and tolerability of varying doses and regimens of inactivated hepatitis A virus vaccine in Navajo children.

Newcomer W, Rivin B, Reid R, Moulton LH, Wolff M, Croll J, Johnson C, Brown L, Nalin D, Santosham M.

Pediatr Infect Dis J. 1994 Jul;13(7):640-2.

PMID:
7970954
15.

Safety profile and immunogenicity of an inactivated vaccine derived from an attenuated strain of hepatitis A.

Ellerbeck EF, Lewis JA, Nalin D, Gershman K, Miller WJ, Armstrong ME, Davide JP, Rhoad AE, McGuire B, Calandra G, et al.

Vaccine. 1992;10(10):668-72.

PMID:
1523877
16.

Simultaneous passive and active immunization against hepatitis A.

Leentvaar-Kuijpers A, Coutinho RA, Brulein V, Safary A.

Vaccine. 1992;10 Suppl 1:S138-41.

PMID:
1335646
17.

Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine: rationale and summary of findings.

André FE, D'Hondt E, Delem A, Safary A.

Vaccine. 1992;10 Suppl 1:S160-8. Review.

PMID:
1335652
18.

Effect of hepatitis A vaccination schedules on immune response.

Tilzey AJ, Palmer SJ, Barrow S, Perry KR, Tyrell H, Safary A, Banatvala JE.

Vaccine. 1992;10 Suppl 1:S121-3.

PMID:
1335640
19.

Immunogenicity and safety of three consecutive lots of a new preservative-free inactivated hepatitis A vaccine (Healive): a double-blind, randomized and controlled trial.

Jiang WP, Chen JT, Wang X, Wang YL, Liu Y, Chen WY, Xu WG, Qiu YZ, Yin WD.

Vaccine. 2008 Apr 24;26(18):2297-301. doi: 10.1016/j.vaccine.2007.11.008. Epub 2007 Nov 26.

PMID:
18395305
20.

Effect of virus strain and antigen dose on immunogenicity and reactogenicity of an inactivated hepatitis A vaccine.

Goubau P, Van Gerven V, Safary A, Delem A, Knops J, D'Hondt E, André FE, Desmyter J.

Vaccine. 1992;10 Suppl 1:S114-8.

PMID:
1335638
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk